Prediction of unsuccessful treatment in patients with severe acute asthma

被引:6
|
作者
Goodacre, Steve [1 ]
Bradburn, Mike [1 ]
Cohen, Judith [1 ]
Gray, Alasdair [2 ]
Benger, Jonathan [3 ]
Coats, Tim [4 ]
机构
[1] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England
[2] Royal Infirm Edinburgh NHS Trust, Emergency Dept, Edinburgh, Midlothian, Scotland
[3] Univ W England, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England
[4] Leicester Royal Infirm, Emergency Dept, Leicester, Leics, England
关键词
PROSPECTIVE MULTICENTER; EMERGENCY-DEPARTMENT; ADMISSION; THERAPY; ADULTS; ROOM;
D O I
10.1136/emermed-2013-203046
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Clinical assessment can be used to identify which patients with acute asthma are at risk of unsuccessful initial treatment. Objective To determine which elements of clinical assessment predict unsuccessful treatment, defined as needing critical care or any unplanned additional treatment. Methods We analysed data from a large multicentre trial (the 3Mg trial). Adults with severe acute asthma underwent standardised clinical assessment, including peak expiratory flow rate (PEFR), up to 2 h after initiation of treatment. Standard care was provided other than blinded random allocation to trial treatment or placebo. Patients were followed up by record review up to 30 days. Unsuccessful treatment was defined as needing (1) critical care or (2) critical care or any unplanned additional treatment within 7 days of presentation. Logistic regression was used to identify predictors and derive a prediction model for each outcome. Results Out of 1084 patients analysed, 81 (7%) received critical care and 157 (14%) received critical care or unplanned additional treatment. Baseline PEFR (p=0.017), baseline heart rate (p<0.001), other serious illness (p=0.019), PEFR change (p=0.015) and heart rate change (p<0.001) predicted need for critical care. Baseline PEFR (p=0.010), baseline heart rate (p<0.001), baseline respiratory rate (p=0.017), other serious illness (p=0.023), PEFR change (p=0.003) and heart rate change (p=0.001) predicted critical care or additional treatment. Models based on these characteristics had c-statistics of 0.77 and 0.69, respectively. Conclusions PEFR, heart rate and other serious illnesses are the best predictors of unsuccessful treatment, but models based on these variables provide modest predictive value.
引用
收藏
页码:E40 / E45
页数:6
相关论文
共 50 条
  • [31] CONTROVERSY - ARE CORTICOSTEROIDS NECESSARY IN THE TREATMENT OF SEVERE ACUTE ASTHMA
    GRANT, IWB
    BRITISH JOURNAL OF DISEASES OF THE CHEST, 1982, 76 (02): : 125 - 129
  • [32] Safety of Terbutaline for Treatment of Acute Severe Pediatric Asthma
    Doymaz, Sule
    Schneider, James
    PEDIATRIC EMERGENCY CARE, 2018, 34 (05) : 299 - 302
  • [33] SHOULD CORTICOSTEROIDS BE USED IN THE TREATMENT OF ACUTE, SEVERE ASTHMA .1. A CASE FOR THE USE OF CORTICOSTEROIDS IN ACUTE, SEVERE ASTHMA
    FIEL, SB
    PHARMACOTHERAPY, 1985, 5 (06): : 327 - 331
  • [34] Severe asthma treatment: need for characterising patients
    Heaney, LG
    Robinson, DS
    LANCET, 2005, 365 (9463): : 974 - 976
  • [35] Treatment of asthma patients under severe conditions
    Marraro, GA
    OPTIMIZATION OF AEROSOL DRUG DELIVERY, 2003, : 277 - 293
  • [36] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [37] THE EFFECT OF MEPOLIZUMAB TREATMENT IN PATIENTS WITH SEVERE ASTHMA
    Sandhu, Yuuki
    Harada, Norihiro
    Matsuno, Kei
    Harada, Sonoko
    Sasano, Hitoshi
    Tanabe, Yuki
    Nakamura, Ai
    Takeshige, Tomohito
    Ishimori, Ayako
    Katsura, Yoko
    Makino, Fumihiko
    Ito, Jun
    Atsuta, Ryo
    Akiba, Hisaya
    Takahashi, Kazuhisa
    RESPIROLOGY, 2017, 22 : 98 - 99
  • [38] THE TREATMENT OF PATIENTS WITH SEVERE ASTHMA AND CHRONIC BRONCHITIS
    OGILVIE, AG
    BRITISH JOURNAL OF TUBERCULOSIS AND DISEASES OF THE CHEST, 1958, 52 (02): : 126 - 133
  • [39] Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
    Havlucu, Yavuz
    Yorgancioglu, Arzu
    Kurhan, Fikret
    Goktalay, Tugba
    Coskun, Aysin Sakar
    Celik, Pinar
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [40] Prediction of response to biological treatment with monoclonal antibodies in severe asthma
    Kroes, J. A.
    Zielhuis, S. W.
    van Roon, E. N.
    ten Brinke, A.
    BIOCHEMICAL PHARMACOLOGY, 2020, 179